194 related articles for article (PubMed ID: 22341969)
1. Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome.
Tanaka A; Weinel S; Nagy N; O'Driscoll M; Lai-Cheong JE; Kulp-Shorten CL; Knable A; Carpenter G; Fisher SA; Hiragun M; Yanase Y; Hide M; Callen J; McGrath JA
Am J Hum Genet; 2012 Mar; 90(3):511-7. PubMed ID: 22341969
[TBL] [Abstract][Full Text] [Related]
2. Primary microcephaly, impaired DNA replication, and genomic instability caused by compound heterozygous ATR mutations.
Mokrani-Benhelli H; Gaillard L; Biasutto P; Le Guen T; Touzot F; Vasquez N; Komatsu J; Conseiller E; Pïcard C; Gluckman E; Francannet C; Fischer A; Durandy A; Soulier J; de Villartay JP; Cavazzana-Calvo M; Revy P
Hum Mutat; 2013 Feb; 34(2):374-84. PubMed ID: 23111928
[TBL] [Abstract][Full Text] [Related]
3. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.
O'Driscoll M; Ruiz-Perez VL; Woods CG; Jeggo PA; Goodship JA
Nat Genet; 2003 Apr; 33(4):497-501. PubMed ID: 12640452
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts.
Tivey HS; Rokicki MJ; Barnacle JR; Rogers MJ; Bagley MC; Kipling D; Davis T
J Gerontol A Biol Sci Med Sci; 2013 Sep; 68(9):1001-9. PubMed ID: 23401567
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
6. Analysis of novel missense ATR mutations reveals new splicing defects underlying Seckel syndrome.
Llorens-Agost M; Luessing J; van Beneden A; Eykelenboom J; O'Reilly D; Bicknell LS; Reynolds JJ; van Koegelenberg M; Hurles ME; Brady AF; Jackson AP; Stewart GS; Lowndes NF
Hum Mutat; 2018 Dec; 39(12):1847-1853. PubMed ID: 30199583
[TBL] [Abstract][Full Text] [Related]
7. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal instability at common fragile sites in Seckel syndrome.
Casper AM; Durkin SG; Arlt MF; Glover TW
Am J Hum Genet; 2004 Oct; 75(4):654-60. PubMed ID: 15309689
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase.
Nam EA; Zhao R; Cortez D
J Biol Chem; 2011 Oct; 286(43):37320-7. PubMed ID: 21908846
[TBL] [Abstract][Full Text] [Related]
10. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling.
Griffith E; Walker S; Martin CA; Vagnarelli P; Stiff T; Vernay B; Al Sanna N; Saggar A; Hamel B; Earnshaw WC; Jeggo PA; Jackson AP; O'Driscoll M
Nat Genet; 2008 Feb; 40(2):232-6. PubMed ID: 18157127
[TBL] [Abstract][Full Text] [Related]
11. Nbs1 is required for ATR-dependent phosphorylation events.
Stiff T; Reis C; Alderton GK; Woodbine L; O'Driscoll M; Jeggo PA
EMBO J; 2005 Jan; 24(1):199-208. PubMed ID: 15616588
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice.
de Klein A; Muijtjens M; van Os R; Verhoeven Y; Smit B; Carr AM; Lehmann AR; Hoeijmakers JH
Curr Biol; 2000 Apr; 10(8):479-82. PubMed ID: 10801416
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the ATR gene in breast and ovarian cancer families.
Heikkinen K; Mansikka V; Karppinen SM; Rapakko K; Winqvist R
Breast Cancer Res; 2005; 7(4):R495-501. PubMed ID: 15987455
[TBL] [Abstract][Full Text] [Related]
14. Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1.
Stiff T; Cerosaletti K; Concannon P; O'Driscoll M; Jeggo PA
Hum Mol Genet; 2008 Oct; 17(20):3247-53. PubMed ID: 18664457
[TBL] [Abstract][Full Text] [Related]
15. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.
Difilippantonio S; Celeste A; Fernandez-Capetillo O; Chen HT; Reina San Martin B; Van Laethem F; Yang YP; Petukhova GV; Eckhaus M; Feigenbaum L; Manova K; Kruhlak M; Camerini-Otero RD; Sharan S; Nussenzweig M; Nussenzweig A
Nat Cell Biol; 2005 Jul; 7(7):675-85. PubMed ID: 15965469
[TBL] [Abstract][Full Text] [Related]
16. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
17. CtIP Mutations Cause Seckel and Jawad Syndromes.
Qvist P; Huertas P; Jimeno S; Nyegaard M; Hassan MJ; Jackson SP; Børglum AD
PLoS Genet; 2011 Oct; 7(10):e1002310. PubMed ID: 21998596
[TBL] [Abstract][Full Text] [Related]
18. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
19. Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint.
Lee AY; Chiba T; Truong LN; Cheng AN; Do J; Cho MJ; Chen L; Wu X
J Biol Chem; 2012 Jan; 287(4):2531-43. PubMed ID: 22123827
[TBL] [Abstract][Full Text] [Related]
20. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
